Undervalued Small Caps With Insider Buying For May 2026

Oncology Institute, Inc.

Oncology Institute, Inc.

TOI

0.00

Over the last 7 days, the United States market has remained flat, yet it has experienced a notable 24% rise over the past year with earnings expected to grow by 17% annually in the coming years. In this context, identifying small-cap stocks that are undervalued and show signs of insider buying can be a strategic approach for investors seeking opportunities that align with these market dynamics.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name PE PS Discount to Fair Value Value Rating
Metropolitan Bank Holding 12.5x 3.6x 41.84% ★★★★★☆
PCB Bancorp 8.3x 2.8x 21.97% ★★★★★☆
First United 9.4x 2.7x 48.44% ★★★★★☆
Appian 1620.0x 1.9x 43.98% ★★★★★☆
First Bancorp 8.6x 3.3x 33.44% ★★★★☆☆
New Peoples Bankshares 8.9x 2.3x 36.87% ★★★★☆☆
Citizens & Northern 21.0x 3.2x 24.58% ★★★☆☆☆
Franklin Financial Services 10.2x 2.7x -21.71% ★★★☆☆☆
Angel Studios NA 1.3x -39.06% ★★★☆☆☆
Ultralife NA 0.5x 19.39% ★★★☆☆☆

Here's a peek at a few of the choices from the screener.

Parke Bancorp (PKBK)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Parke Bancorp is a community banking institution with operations focused on providing financial services, and it has a market capitalization of approximately $0.18 billion.

Operations: The company primarily generates revenue through community banking, with a recent quarterly revenue of $83.33 million. Operating expenses are significant, with general and administrative costs being a major component at $21.31 million in the most recent period. The net income margin has shown variability, reaching 50.19% in the latest quarter, reflecting changes in profitability over time.

PE: 8.4x

Parke Bancorp stands out in the small-cap arena with a recent boost in net interest income to US$22.13 million for Q1 2026, up from US$16.61 million the previous year, reflecting solid financial health despite a 4.1% annual earnings decline over five years. Insider confidence is evident with share purchases between March and April 2026, signaling trust in future prospects. The company also increased its quarterly dividend to US$0.20 per share, enhancing shareholder value amidst ongoing earnings challenges.

PKBK Share price vs Value as at May 2026
PKBK Share price vs Value as at May 2026

Oncology Institute (TOI)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: The Oncology Institute operates in the healthcare sector, providing patient services, specialty pharmacy solutions, and clinical trials, with a market cap of $1.24 billion.

Operations: The company generates revenue primarily from Specialty Pharmacy and Patient Services, with a smaller contribution from Clinical Trials. Over the years, the gross profit margin has shown some fluctuations, most recently recorded at 15.12% in March 2026. Operating expenses are dominated by General & Administrative costs.

PE: -11.0x

The Oncology Institute, a smaller player in the healthcare sector, has shown significant revenue growth with US$147.44 million reported for Q1 2026, up from US$104.41 million the previous year. Despite not achieving profitability yet and relying on external borrowing for funding, insider confidence is evident through recent share purchases. The addition of Minh Merchant as Chief Legal Officer aims to bolster its regulatory and compliance capabilities as it scales operations, suggesting potential future growth despite current challenges.

TOI Ownership Breakdown as at May 2026
TOI Ownership Breakdown as at May 2026

Strattec Security (STRT)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Strattec Security is a company that specializes in the production of automotive parts and accessories, with a market capitalization of approximately $0.08 billion.

Operations: The company generates revenue primarily from the Auto Parts & Accessories segment, with recent figures showing $579.58 million in revenue. The cost of goods sold (COGS) is a significant component of expenses, impacting its gross profit margin which was 16.76% as of the latest period. Operating expenses are another major cost factor, contributing to overall financial performance and net income outcomes.

PE: 11.2x

Strattec Security, a smaller player in the security solutions sector, recently reported a dip in quarterly sales to US$137.63 million from US$144.08 million the previous year, with net income also falling to US$3.24 million. Despite this decline, their nine-month figures show growth in net income to US$16.72 million from last year’s US$10.42 million, suggesting potential value overlooked by the market. Insider confidence is evident as insiders have been purchasing shares over recent months, indicating belief in future prospects despite forecasts of earnings decline by 7% annually over three years and reliance on external borrowing for funding.

STRT Share price vs Value as at May 2026
STRT Share price vs Value as at May 2026

Taking Advantage

  • Navigate through the entire inventory of 69 Undervalued US Small Caps With Insider Buying here.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready For A Different Approach?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.